← All patents

US20170059556A1

Therapies for Cancer Using RLIP76

University of Texas System

Abstract

The present invention is a composition identified as a region of ralA binding protein 1, wherein the region neighbors a membrane-associated portion of the ralA binding protein 1, reduces transport activity and membrane association of the ralA binding protein 1 and kills cells undergoing …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Sanjay Aswasthi
Priority date
November 13, 2002
Filing date
November 10, 2016
Publication date
March 02, 2017
Language
en
Metadata fetched
August 29, 2026 00:24